EMA Authorised: Effentora (fentanyl) — Phoenix Labs Unlimited Company

View source ↗

Summary

The EMA has authorised Effentora (fentanyl) by Phoenix Labs Unlimited Company for the treatment of breakthrough cancer pain in opioid-tolerant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Effentora (Fentanyl)

Snippet

Status: Authorised. Therapeutic area: Pain;Cancer. MAH: Phoenix Labs Unlimited Company. Decision date: 09/01/2026